Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
4.1. Generation of the Villin-PPARD Mouse Model and Gastric Tissue Collection
4.2. NMR Data Acquisition
4.3. Ex Vivo Metabolite Pool Size Measurements
4.4. Magnetic Resonance Imaging and Hyperpolarized MR Data Acquisition
4.5. Mass Spectrometry
4.6. Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87–108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, Y.C.; Lin, J.T. Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level. J. Gastroenterol. Hepatol. 2017, 32, 1160–1169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Casamayor, M.; Morlock, R.; Maeda, H.; Ajani, J. Targeted literature review of the global burden of gastric cancer. Ecancermedicalscience 2018, 12, 883. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Neels, J.G.; Grimaldi, P.A. Physiological functions of peroxisome proliferator-activated receptor beta. Physiol. Rev. 2014, 94, 795–858. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Billin, A.N. PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: An adopted orphan still looking for a home. Expert Opin. Investig. Drugs 2008, 17, 1465–1471. [Google Scholar] [CrossRef] [PubMed]
- Beyaz, S.; Mana, M.D.; Roper, J.; Kedrin, D.; Saadatpour, A.; Hong, S.J.; Bauer-Rowe, K.E.; Xifaras, M.E.; Akkad, A.; Arias, E.; et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 2016, 531, 53–58. [Google Scholar] [CrossRef]
- Pollock, C.B.; Rodriguez, O.; Martin, P.L.; Albanese, C.; Li, X.; Kopelovich, L.; Glazer, R.I. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptordelta activation. PPAR Res. 2010, 2010, 571783. [Google Scholar] [CrossRef]
- Pollock, C.B.; Yin, Y.; Yuan, H.; Zeng, X.; King, S.; Li, X.; Kopelovich, L.; Albanese, C.; Glazer, R.I. PPARdelta activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis. PLoS ONE 2011, 6, e16215. [Google Scholar] [CrossRef]
- Grygiel-Górniak, B. Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications – a review. Nutr. J. 2014, 13, 17. [Google Scholar] [CrossRef] [Green Version]
- Forman, B.M.; Chen, J.; Evans, R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA 1997, 94, 4312–4317. [Google Scholar] [CrossRef] [Green Version]
- Xu, M.; Zuo, X.; Shureiqi, I. Targeting peroxisome proliferator-activated receptor-beta/delta in colon cancer: How to aim? Biochem. Pharmacol. 2013, 85, 607–611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peters, J.M.; Gonzalez, F.J.; Muller, R. Establishing the Role of PPARbeta/delta in Carcinogenesis. Trends Endocrinol. Metab. 2015, 26, 595–607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yuan, H.; Lu, J.; Xiao, J.; Upadhyay, G.; Umans, R.; Kallakury, B.; Yin, Y.; Fant, M.E.; Kopelovich, L.; Glazer, R.I. PPARdelta induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation. Cancer Res. 2013, 73, 4349–4361. [Google Scholar] [CrossRef] [Green Version]
- Gupta, R.A.; Tan, J.; Krause, W.F.; Geraci, M.W.; Willson, T.M.; Dey, S.K.; DuBois, R.N. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl. Acad. Sci. USA 2000, 97, 13275–13280. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zuo, X.; Xu, W.; Xu, M.; Tian, R.; Moussalli, M.J.; Mao, F.; Zheng, X.; Wang, J.; Morris, J.S.; Gagea, M.; et al. Metastasis regulation by PPARD expression in cancer cells. JCI Insight 2017, 2, e91419. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pedchenko, T.V.; Gonzalez, A.L.; Wang, D.; DuBois, R.N.; Massion, P.P. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer. Am. J. Respir. Cell Mol. Biol. 2008, 39, 689–696. [Google Scholar] [CrossRef] [Green Version]
- Jaeckel, E.C.; Raja, S.; Tan, J.; Das, S.K.; Dey, S.K.; Girod, D.A.; Tsue, T.T.; Sanford, T.R. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2001, 127, 1253–1259. [Google Scholar] [CrossRef] [Green Version]
- Shao, J.; Sheng, H.; DuBois, R.N. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res. 2002, 62, 3282–3288. [Google Scholar]
- He, T.C.; Chan, T.A.; Vogelstein, B.; Kinzler, K.W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999, 99, 335–345. [Google Scholar] [CrossRef] [Green Version]
- Montagner, A.; Delgado, M.B.; Tallichet-Blanc, C.; Chan, J.S.; Sng, M.K.; Mottaz, H.; Degueurce, G.; Lippi, Y.; Moret, C.; Baruchet, M.; et al. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor beta/delta in ultraviolet radiation-induced skin cancer. EMBO Mol. Med. 2014, 6, 80–98. [Google Scholar] [CrossRef]
- Park, B.H.; Vogelstein, B.; Kinzler, K.W. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci. USA 2001, 98, 2598–2603. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kwak, H.; Hwang, I.; Kim, J.H.; Kim, M.Y.; Yang, J.S.; Jeong, S. Modulation of transcription by the peroxisome proliferator-activated receptor delta--binding RNA aptamer in colon cancer cells. Mol. Cancer Ther. 2009, 8, 2664–2673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zuo, X.; Peng, Z.; Moussalli, M.J.; Morris, J.S.; Broaddus, R.R.; Fischer, S.M.; Shureiqi, I. Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis. J. Natl. Cancer Inst. 2009, 101, 762–767. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zuo, X.; Deguchi, Y.; Xu, W.; Liu, Y.; Li, H.S.; Wei, D.; Tian, R.; Chen, W.; Xu, M.; Yang, Y.; et al. PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice. Gastroenterology 2019, 157, 163–178. [Google Scholar] [CrossRef]
- Zacharias, N.; Lee, J.; Ramachandran, S.; Shanmugavelandy, S.; McHenry, J.; Dutta, P.; Millward, S.; Gammon, S.; Efstathiou, E.; Troncoso, P.; et al. Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo. Mol. Imaging Biol. 2019, 21, 86–94. [Google Scholar] [CrossRef]
- Dutta, P.; Salzillo, T.C.; Pudakalakatti, S.; Gammon, S.T.; Kaipparettu, B.A.; McAllister, F.; Wagner, S.; Frigo, D.E.; Logothetis, C.J.; Zacharias, N.M.; et al. Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging. Cells 2019, 8, 340. [Google Scholar] [CrossRef] [Green Version]
- Dutta, P.; Perez, M.R.; Lee, J.; Kang, Y.; Pratt, M.; Salzillo, T.C.; Weygand, J.; Zacharias, N.M.; Gammon, S.T.; Koay, E.J.; et al. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy to Identify Metabolic Biomarkers in Pancreatic Cancer. J. Proteome Res. 2019, 18, 2826–2834. [Google Scholar] [CrossRef]
- Golman, K.; Olsson, L.E.; Axelsson, O.; Månsson, S.; Karlsson, M.; Petersson, J.S. Molecular imaging using hyperpolarized 13C. Br. J. Radiol. 2003, 76, S118–S127. [Google Scholar] [CrossRef]
- Harmon, G.S.; Lam, M.T.; Glass, C.K. PPARs and Lipid Ligands in Inflammation and Metabolism. Chem. Rev. 2011, 111, 6321–6340. [Google Scholar] [CrossRef] [Green Version]
- Xu, H.E.; Lambert, M.H.; Montana, V.G.; Parks, D.J.; Blanchard, S.G.; Brown, P.J.; Sternbach, D.D.; Lehmann, J.M.; Wisely, G.B.; Willson, T.M.; et al. Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors. Mol. Cell 1999, 3, 397–403. [Google Scholar] [CrossRef]
- Shureiqi, I.; Jiang, W.; Zuo, X.; Wu, Y.; Stimmel, J.B.; Leesnitzer, L.M.; Morris, J.S.; Fan, H.-Z.; Fischer, S.M.; Lippman, S.M. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal ca ncer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 9968. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barish, G.D.; Narkar, V.A.; Evans, R.M. PPAR delta: A dagger in the heart of the metabolic syndrome. J. Clin. Investig. 2006, 116, 590–597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, L.; Zhang, H.; Zhou, Z.-G.; Yan, H.; Adell, G.; Sun, X.-F. Biological Function and Prognostic Significance of Peroxisome Proliferator-Activated Receptor δ in Rectal Cancer. Clin. Cancer Res. 2011, 17, 3760–3770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Röhrl, C.; Kaindl, U.; Koneczny, I.; Hudec, X.; Baron, D.M.; König, J.S.; Marian, B. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells. J. Cancer Res. Clin. Oncol. 2011, 137, 29–39. [Google Scholar] [CrossRef] [PubMed]
- Pazienza, V.; Vinciguerra, M.; Mazzoccoli, G. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Res. 2012, 2012, 560846. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Okazaki, M.; Iwasaki, Y.; Nishiyama, M.; Taguchi, T.; Tsugita, M.; Nakayama, S.; Kambayashi, M.; Hashimoto, K.; Terada, Y. PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr. J. 2010, 57, 403–413. [Google Scholar] [CrossRef] [Green Version]
- Lee, W.H.; Kim, S.G. AMPK-Dependent Metabolic Regulation by PPAR Agonists. PPAR Res. 2010, 2010, 549101. [Google Scholar] [CrossRef]
- Zhang, B.B.; Zhou, G.; Li, C. AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metabol. 2009, 9, 407–416. [Google Scholar] [CrossRef] [Green Version]
- Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [Green Version]
- DeBerardinis, R.J.; Chandel, N.S. Fundamentals of cancer metabolism. Sci. Adv. 2016, 2, e1600200. [Google Scholar] [CrossRef] [Green Version]
- Pavlova, N.N.; Thompson, C.B. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016, 23, 27–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shim, H.; Dolde, C.; Lewis, B.C.; Wu, C.S.; Dang, G.; Jungmann, R.A.; Dalla-Favera, R.; Dang, C.V. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 1997, 94, 6658–6663. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029–1033. [Google Scholar] [CrossRef] [Green Version]
- Zuo, X.; Xu, M.; Yu, J.; Wu, Y.; Moussalli, M.J.; Manyam, G.C.; Lee, S.I.; Liang, S.; Gagea, M.; Morris, J.S.; et al. Potentiation of Colon Cancer Susceptibility in Mice by Colonic Epithelial PPAR-δ/β Overexpression. J. Natl. Cancer Inst. 2014, 106, dju052. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pudakalakatti, S.M.; Uppangala, S.; D’Souza, F.; Kalthur, G.; Kumar, P.; Adiga, S.K.; Atreya, H.S. NMR studies of preimplantation embryo metabolism in human assisted reproductive techniques: A new biomarker for assessment of embryo implantation potential. NMR Biomed. 2013, 26, 20–27. [Google Scholar] [CrossRef] [PubMed]
- Pudakalakatti, S.; Audia, A.; Mukhopadhyay, A.; Enriquez, J.S.; Bourgeois, D.; Tayob, N.; Zacharias, N.M.; Millward, S.W.; Carson, D.; Farach-Carson, M.C.; et al. NMR Spectroscopy-Based Metabolomics of Platelets to Analyze Brain Tumors. Reports 2021, 4, 32. [Google Scholar] [CrossRef]
- Wishart, D.S.; Jewison, T.; Guo, A.C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; et al. HMDB 3.0—The Human Metabolome Database in 2013. Nucleic Acids Res. 2013, 41, D801–D807. [Google Scholar] [CrossRef]
- Salzillo, T.C.; Mawoneke, V.; Weygand, J.; Shetty, A.; Gumin, J.; Zacharias, N.M.; Gammon, S.T.; Piwnica-Worms, D.; Fuller, G.N.; Logothetis, C.J.; et al. Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells 2021, 10, 2621. [Google Scholar] [CrossRef]
- Mochizuki, Y.; Inagaki, S.; Suzuki, M.; Min, J.Z.; Inoue, K.; Todoroki, K.; Toyo’oka, T. A novel derivatization reagent possessing a bromoquinolinium structure for biological carboxylic acids in HPLC-ESI-MS/MS. J. Sep. Sci. 2013, 36, 1883–1889. [Google Scholar] [CrossRef]
- Metsalu, T.; Vilo, J. ClustVis: A web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015, 43, W566–W570. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pudakalakatti, S.; Titus, M.; Enriquez, J.S.; Ramachandran, S.; Zacharias, N.M.; Shureiqi, I.; Liu, Y.; Yao, J.C.; Zuo, X.; Bhattacharya, P.K. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. Int. J. Mol. Sci. 2022, 23, 1645. https://doi.org/10.3390/ijms23031645
Pudakalakatti S, Titus M, Enriquez JS, Ramachandran S, Zacharias NM, Shureiqi I, Liu Y, Yao JC, Zuo X, Bhattacharya PK. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. International Journal of Molecular Sciences. 2022; 23(3):1645. https://doi.org/10.3390/ijms23031645
Chicago/Turabian StylePudakalakatti, Shivanand, Mark Titus, José S. Enriquez, Sumankalai Ramachandran, Niki M. Zacharias, Imad Shureiqi, Yi Liu, James C. Yao, Xiangsheng Zuo, and Pratip K. Bhattacharya. 2022. "Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors" International Journal of Molecular Sciences 23, no. 3: 1645. https://doi.org/10.3390/ijms23031645